|
| 36724681 | An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers. | EBioMedicine | 2023 |
| 37463882 | Next generation pan-cancer blood proteome profiling using proximity extension assay. | Nat Commun | 2023 |
| 34844098 | Combined expression of HOXA11 and CD10 identifies endometriosis versus normal tissue and tumors. | Ann Diagn Pathol | 2022 |
| 35406529 | Next Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian Cancer. | Cancers (Basel) | 2022 |
| 36469776 | Noninvasive detection of any-stage cancer using free glycosaminoglycans. | Proc Natl Acad Sci U S A | 2022 |
| 34771707 | The Immune Landscape of Colorectal Cancer. | Cancers (Basel) | 2021 |
| 33706249 | The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types. | EBioMedicine | 2021 |
| 34911754 | A gene-centric approach to biomarker discovery identifies transglutaminase 1 as an epidermal autoantigen. | Proc Natl Acad Sci U S A | 2021 |
| 32139877 | Lipogenic signalling modulates prostate cancer cell adhesion and migration via modification of Rho GTPases. | Oncogene | 2020 |
| 31924107 | Molecular characterization of a large unselected cohort of metastatic colorectal cancers in relation to primary tumor location, rare metastatic sites and prognosis. | Acta Oncol | 2020 |
| 31769323 | Metastatic colorectal carcinomas with high SATB2 expression are associated with better prognosis and response to chemotherapy: a population-based Scandinavian study. | Acta Oncol | 2020 |
| 32117703 | CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better <i>BRAF</i> Mutated and a Worse <i>KRAS</i> Mutated Subgroup. | Front Oncol | 2020 |
| 31070306 | Consequences of a high incidence of microsatellite instability and BRAF-mutated tumors: A population-based cohort of metastatic colorectal cancer patients. | Cancer Med | 2019 |
| 30109401 | Region-by-region analysis of PET, MRI, and histology in en bloc-resected oligodendrogliomas reveals intra-tumoral heterogeneity. | Eur J Nucl Med Mol Imaging | 2019 |
| 28631533 | U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden. | Acta Oncol | 2018 |
| 30172673 | Affibody-derived drug conjugates: Potent cytotoxic molecules for treatment of HER2 over-expressing tumors. | J Control Release | 2018 |
| 30272454 | Integration of Transcriptomics and Antibody-Based Proteomics for Exploration of Proteins Expressed in Specialized Tissues. | J Proteome Res | 2018 |
| 29486992 | Combined ASRGL1 and p53 immunohistochemistry as an independent predictor of survival in endometrioid endometrial carcinoma. | Gynecol Oncol | 2018 |
| 29096882 | Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesions. | Gynecol Oncol | 2018 |
| 27301795 | Expression of possible targets for new proteasome inhibitors in diffuse large B-cell lymphoma. | Eur J Haematol | 2017 |
| 28260162 | Tumoral cubilin is a predictive marker for treatment of renal cancer patients with sunitinib and sorafenib. | J Cancer Res Clin Oncol | 2017 |
| 28433799 | Affinity Proteomics Exploration of Melanoma Identifies Proteins in Serum with Associations to T-Stage and Recurrence. | Transl Oncol | 2017 |
| 28445977 | Serglycin as a potential biomarker for glioma: association of serglycin expression, extent of mast cell recruitment and glioblastoma progression. | Oncotarget | 2017 |
| 29107068 | Targeting tumor cells based on Phosphodiesterase 3A expression. | Exp Cell Res | 2017 |
| 29142246 | A comprehensive structural, biochemical and biological profiling of the human NUDIX hydrolase family. | Nat Commun | 2017 |
| 29187872 | Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients. | J Cancer | 2017 |
| 28756482 | EPR Oximetry of Cetuximab-Treated Head-and-Neck Tumours in a Mouse Model. | Cell Biochem Biophys | 2017 |
| 28818916 | A pathology atlas of the human cancer transcriptome. | Science | 2017 |
| 28052770 | A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma. | BMC Cancer | 2017 |
| 28036101 | Cetuximab sensitivity of head and neck squamous cell carcinoma xenografts is associated with treatment-induced reduction in EGFR, pEGFR, and pSrc. | J Oral Pathol Med | 2017 |
| 26918468 | Extension of diffuse low-grade gliomas beyond radiological borders as shown by the coregistration of histopathological and magnetic resonance imaging data. | J Neurosurg | 2016 |
| 27974665 | The protein phosphatase 2A regulatory subunit PR70 is a gonosomal melanoma tumor suppressor gene. | Sci Transl Med | 2016 |
| 27656710 | A stromal cell population in the large intestine identified by tissue factor expression that is lost during colorectal cancer progression. | Thromb Haemost | 2016 |
| 27626492 | PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status. | Oncotarget | 2016 |
| 27565180 | Heparanase Promotes Glioma Progression and Is Inversely Correlated with Patient Survival. | Mol Cancer Res | 2016 |
| 27262585 | SATB2 is expressed in Merkel cell carcinoma. | Arch Dermatol Res | 2016 |
| 27486389 | Horizontal Cells, the Odd Ones Out in the Retina, Give Insights into Development and Disease. | Front Neuroanat | 2016 |
| 26830021 | Proteome-wide survey of the autoimmune target repertoire in autoimmune polyendocrine syndrome type 1. | Sci Rep | 2016 |
| 25263081 | FGF2 as a potential prognostic biomarker for proneural glioma patients. | Acta Oncol | 2015 |
| 25858696 | Loss of ASRGL1 expression is an independent biomarker for disease-specific survival in endometrioid endometrial carcinoma. | Gynecol Oncol | 2015 |
| 25411189 | Expression of human skin-specific genes defined by transcriptomics and antibody-based profiling. | J Histochem Cytochem | 2015 |
| 25613900 | Proteomics. Tissue-based map of the human proteome. | Science | 2015 |
| 24262892 | Detection of the human endogenous retrovirus ERV3-encoded Env-protein in human tissues using antibody-based proteomics. | J R Soc Med | 2014 |
| 24510345 | PTPN6 expression is epigenetically regulated and influences survival and response to chemotherapy in high-grade gliomas. | Tumour Biol | 2014 |
| 24330150 | A systematic analysis of commonly used antibodies in cancer diagnostics. | Histopathology | 2014 |
| 24410805 | Subtyping of gliomas of various WHO grades by the application of immunohistochemistry. | Histopathology | 2014 |
| 24037901 | A study of embryonic stem cell-related proteins in human astrocytomas: identification of Nanog as a predictor of survival. | Int J Cancer | 2014 |
| 24091309 | Glioma-derived macrophage migration inhibitory factor (MIF) promotes mast cell recruitment in a STAT5-dependent manner. | Mol Oncol | 2014 |
| 23276153 | Contribution of antibody-based protein profiling to the human Chromosome-centric Proteome Project (C-HPP). | J Proteome Res | 2013 |
| 23690928 | A texture based pattern recognition approach to distinguish melanoma from non-melanoma cells in histopathological tissue microarray sections. | PLoS One | 2013 |